Free Trial

What is Roth Capital's Forecast for InfuSystem Q2 Earnings?

InfuSystem logo with Medical background

InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) - Stock analysts at Roth Capital issued their Q2 2025 EPS estimates for shares of InfuSystem in a research note issued to investors on Monday, July 21st. Roth Capital analyst K. Bauser forecasts that the company will post earnings per share of $0.03 for the quarter. Roth Capital currently has a "Strong-Buy" rating on the stock. The consensus estimate for InfuSystem's current full-year earnings is $0.15 per share. Roth Capital also issued estimates for InfuSystem's Q3 2025 earnings at $0.06 EPS, Q4 2025 earnings at $0.06 EPS, FY2025 earnings at $0.13 EPS, Q1 2026 earnings at $0.05 EPS, Q2 2026 earnings at $0.08 EPS, Q3 2026 earnings at $0.11 EPS, Q4 2026 earnings at $0.07 EPS, FY2026 earnings at $0.30 EPS and FY2027 earnings at $0.49 EPS.

A number of other equities analysts also recently issued reports on INFU. B. Riley raised shares of InfuSystem to a "strong-buy" rating in a report on Thursday, May 8th. Wall Street Zen downgraded shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a report on Wednesday, May 14th.

View Our Latest Report on InfuSystem

InfuSystem Stock Performance

Shares of INFU traded up $0.10 on Thursday, reaching $6.01. The company's stock had a trading volume of 104,786 shares, compared to its average volume of 153,565. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The stock has a market capitalization of $126.31 million, a P/E ratio of 100.18 and a beta of 1.81. The stock's 50 day simple moving average is $5.95 and its two-hundred day simple moving average is $6.27. InfuSystem has a 12-month low of $4.61 and a 12-month high of $9.97.

Institutional Investors Weigh In On InfuSystem

A number of institutional investors and hedge funds have recently added to or reduced their stakes in INFU. CWM LLC raised its stake in InfuSystem by 1,160.1% during the 2nd quarter. CWM LLC now owns 4,826 shares of the company's stock worth $30,000 after acquiring an additional 4,443 shares during the period. BNP Paribas Financial Markets raised its stake in InfuSystem by 67.9% during the 4th quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company's stock worth $58,000 after acquiring an additional 2,768 shares during the period. Jump Financial LLC bought a new stake in InfuSystem during the 1st quarter worth approximately $58,000. Williams & Novak LLC bought a new stake in InfuSystem during the 2nd quarter worth approximately $77,000. Finally, Wells Fargo & Company MN raised its stake in InfuSystem by 51.7% during the 4th quarter. Wells Fargo & Company MN now owns 9,286 shares of the company's stock worth $78,000 after acquiring an additional 3,165 shares during the period. Institutional investors own 71.13% of the company's stock.

About InfuSystem

(Get Free Report)

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Featured Stories

Earnings History and Estimates for InfuSystem (NYSE:INFU)

Should You Invest $1,000 in InfuSystem Right Now?

Before you consider InfuSystem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InfuSystem wasn't on the list.

While InfuSystem currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines